Enovix Corporation (NASDAQ:ENVX) Given Consensus Recommendation of “Moderate Buy” by Analysts

Enovix Corporation (NASDAQ:ENVXGet Free Report) has been given an average recommendation of “Moderate Buy” by the ten research firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has given a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $12.6364.

A number of research firms have recently weighed in on ENVX. Wall Street Zen raised shares of Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Bank of America assumed coverage on shares of Enovix in a research report on Thursday, March 12th. They set a “neutral” rating and a $6.00 price target for the company. TD Cowen reissued a “buy” rating on shares of Enovix in a research note on Thursday, May 14th. Craig Hallum cut their price objective on shares of Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a report on Thursday, May 14th. Finally, Benchmark decreased their target price on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday, May 14th.

Check Out Our Latest Analysis on ENVX

Enovix Stock Performance

NASDAQ ENVX opened at $5.36 on Friday. The firm has a market capitalization of $1.17 billion, a PE ratio of -6.46 and a beta of 2.26. The stock’s 50 day moving average is $6.74 and its 200 day moving average is $6.56. Enovix has a twelve month low of $4.61 and a twelve month high of $16.49. The company has a quick ratio of 10.65, a current ratio of 10.97 and a debt-to-equity ratio of 2.14.

Enovix (NASDAQ:ENVXGet Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.01. The business had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The firm’s quarterly revenue was up 49.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Research analysts forecast that Enovix will post -0.79 earnings per share for the current fiscal year.

Institutional Trading of Enovix

Several hedge funds and other institutional investors have recently made changes to their positions in ENVX. Private Advisor Group LLC raised its stake in Enovix by 2.7% during the third quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock valued at $464,000 after buying an additional 1,242 shares during the last quarter. Parallel Advisors LLC grew its stake in shares of Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares during the last quarter. Equitable Holdings Inc. grew its stake in shares of Enovix by 10.9% in the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock worth $137,000 after acquiring an additional 1,342 shares during the last quarter. NewEdge Advisors LLC increased its holdings in shares of Enovix by 4.7% during the first quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock valued at $215,000 after acquiring an additional 1,853 shares in the last quarter. Finally, Mariner LLC increased its holdings in shares of Enovix by 3.4% during the third quarter. Mariner LLC now owns 58,343 shares of the company’s stock valued at $582,000 after acquiring an additional 1,921 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

About Enovix

(Get Free Report)

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.

Featured Articles

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.